NIH-funded research R01 grant

Using GPNMB to help heal bones

Official title: Delivery of GPNMB Therapeutics for Bone Regeneration

Funded at Northeast Ohio Medical University · NIH-11058411 · Data updated 2026-11-12

This study is exploring a new way to help bones heal using a special protein called GPNMB delivered through a gel, which could offer a safer and more effective option for people needing bone regeneration instead of traditional bone grafts.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNortheast Ohio Medical University
NIH-funded
Lab location1 site (Rootstown, United States)
Project startMarch 18, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$394,202
NIH project number5R01AR083763-02
Project IDNIH-11058411 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals requiring bone regeneration, particularly those who may face complications from traditional grafting methods.

Less likely to help

Patients with conditions that do not require bone regeneration or those who have contraindications for the use of GPNMB therapeutics may not benefit from this research.

What this research studies

This research investigates a new treatment for bone regeneration using a protein called GPNMB, which has been shown to promote bone formation. The approach involves delivering GPNMB therapeutics through a specialized hydrogel that ensures the protein reaches the targeted area effectively. This method aims to overcome the limitations of traditional bone grafts, such as donor site complications and limited availability. Patients may benefit from a less invasive and more effective alternative for bone healing.

Why it matters

Potential benefit: If successful, this research could provide a safer and more effective method for bone regeneration, reducing the need for autologous bone grafts.

How similar studies have gone: Previous research has shown promise in using similar therapeutic agents for bone regeneration, indicating potential for success in this innovative approach.

Where this research is happening

  • Northeast Ohio Medical University
    Rootstown, United States
    Active

Researchers

  • Principal investigator: Oyewumi, Moses O — Northeast Ohio Medical University
  • Study coordinator: Oyewumi, Moses O

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.